RxDoctor Payments Data

Victor Gordo Gonzalez, MD

Internal Medicine · San Juan, PRNPI 1124113899

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (48.1%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Johnson & Johnson accounts for 77.4% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2019 at $10,657 and has fallen 99.1% since, to $92 in 2025. Among internal medicine clinicians in PR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$21,394in general payments, 2019–2025

Across 112 payments — averaging $191.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$17K
  • Merck$2K
  • Penumbra, Inc.$1K
  • AstraZeneca$477
  • Sanofi-aventis U.S. LLC$474
  • Boehringer Ingelheim$295
  • plus $592 from 10 others

What the payments were for

  • Consulting fees$5,70027%
  • Speaking & faculty fees$10,30048%
  • Travel & lodging$2,40711%
  • Food & beverage$2,94614%
  • Education$410%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson28$16,551
Merck7$1,714
Penumbra, Inc.3$1,291
AstraZeneca26$477
Sanofi-aventis U.S. LLC15$474
Boehringer Ingelheim9$295
E.r. Squibb & Sons, L.L.C.5$225
PBG Puerto Rico LLC5$95
Eli Lilly Export S.A. Puerto Rico Branch3$62
Amgen2$42
Novo Nordisk2$38
Mylan LLC2$31
Medtronic2$30
GSK1$26
Teva Pharmaceuticals USA, Inc.1$25
Pfizer Pharmaceuticals LLC1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,394 in reported general payments places this provider in the 95th percentile of 1,043 internal medicine providers in Puerto Rico.

See all internal medicine providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$16,308
Medicare patients
69
Services billed
214

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol569$647,503
JardianceEmpagliflozin109$139,340
EliquisApixaban127$137,149
XareltoRivaroxaban102$111,038
SynthroidLevothyroxine Sodium990$106,124
JanumetSitagliptin Phos/Metformin Hcl92$85,114
OzempicSemaglutide63$76,524
TrulicityDulaglutide53$74,097
Trijardy XrEmpaglifloz/Linaglip/Metformin64$62,052
JanuviaSitagliptin Phosphate44$56,024
MounjaroTirzepatide24$40,067
Synjardy XrEmpagliflozin/Metformin Hcl25$32,205
Xigduo XrDapaglifloz Propaned/Metformin34$28,965
EntrestoSacubitril/Valsartan24$28,894
Janumet XrSitagliptin Phos/Metformin Hcl39$26,871

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Brilinta$477$660,225589 claims
Boehringer IngelheimJardiance, Trijardy Xr, Synjardy Xr, Tradjenta, Glyxambi$295$286,033260 claims
MerckJanumet, Januvia, Janumet Xr$1,714$168,008175 claims
Johnson & JohnsonXarelto$16,551$111,038102 claims
Novo NordiskOzempic$38$76,52463 claims
Sanofi-aventis U.S. LLCLantus$474$19,899107 claims
GSKTrelegy Ellipta$26$15,22119 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,043 internal medicine providers in Puerto Rico.

Other internal medicine in San Juan

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →